Last reviewed · How we verify

NCT05982951

A Comparative Study Between Ultrasound Guided Shoulder Block and Pericapsular Nerve Group Bock for Shoulder Arthroscopic Surgeries: Double Blinded Randomized Clinical Trial

Active, enrolled NA Last updated 14 May 2024
What this trial tests

NA trial testing Shoulder PENG block in Efficacy of PENG Block Managing Perioperative Pain With Shoulder Arthroscopy Surgeries in 50 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 January 2024
Primary endpoint
1 August 2024
5 August 2024

Quick facts

Lead sponsorGeneral Committee of Teaching Hospitals and Institutes, Egypt
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment50
Start date1 January 2024
Primary completion1 August 2024
Estimated completion5 August 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

General Committee of Teaching Hospitals and Institutes, Egypt

Who can join

Adults 18 to 60, any sex, with Efficacy of PENG Block Managing Perioperative Pain With Shoulder Arthroscopy Surgeries or Efficacy of Shoulder Block in Managing Perioperative Pain With Shoulder Arthroscopy Surgeries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Shoulder arthroscopic surgeries are one of the most common procedures performed daily in our practice. The arthroscopic techniques offer a less invasive option as Open repair does not offer a significantly better 2-year result in terms of stability, and furthermore, can negatively affect the recovery of the full range of motion of the shoulder. Open techniques Shoulder procedures are performed arthroscopically nowadays with fewer complications compared with open surgery. Indications of shoulder arthroscopy are expanding and include biceps tears, labral tears, rotator muscle tears, subacromial impingements chondral injuries, loose bodies, early degenerative changes, adhesive capsulitis, shoulder instability and acromioclavicular osteoarthritis. There are many regional anesthetic techniques used to control perioperative pain during arthroscopic procedures. Interscalene block results in effective shoulder surgery analgesia, but it is associated with various complications such as diaphragmatic paralysis due to the high incidence of phrenic nerve block. The suprascapular nerve block combined with the axillary nerve block is non-inferior to conventional inter-scalene block except for the early recovery period with the advantage of lower incidence of dyspnea and discomfort. . In a cadaveric anatomical study that the posterosuperior quadrant and the posteroinferior quadrant of the GHJ were innervated by the suprascapular nerve and the axillary nerve respectively. While the anterosuperior quadrant portion of the joint is sensory supplied by the subscapularis superior branch and the anteroinferior by the main branch of the axillary nerve. These anatomical data the possibility of a new block targeting the GHJ sensory branches. It was suggested that deep pericapsular infiltration of local anesthetic towards the subscapularis may cover the axillary and subscapularis branches that feed the anteroinferior and superior quadrants of the GHJ. Recently, the pericapsular nerve group block of the shoulder joint as described in a case series including two cases underwent a humeral neck fracture fixation and Bankart arthroscopic repair with promising anesthesia and analgesia in selected shoulder surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other General Committee of Teaching Hospitals and Institutes, Egypt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05982951.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing